Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
938 studies found for:    Open Studies | "Insulin"
Show Display Options
Rank Status Study
21 Recruiting Benefits of Insulin Supplementation for Correction of Hyperglycemia in Patients With Type 2 Diabetes
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Insulin glargine;   Drug: Insulin aspart;   Drug: Supplemental insulin aspart
22 Unknown  Effect of Intensive Insulin Therapy on Clinical Prognosis of Infants Undergoing Cardiac Surgery
Condition: Cardiac Surgery
Interventions: Other: Intensive insulin therapy;   Other: Conventional insulin therapy
23 Unknown  The Management of Glucocorticoid-Induced Hyperglycemia in Hospitalized Patients
Conditions: Hyperglycemia;   Diabetes Mellitus
Interventions: Drug: Active Comparator: Glargine/Lispro insulin;   Drug: Glargine/Lispro/NPH insulin arm
24 Unknown  TReatment by Insulin Continuous Infusion in Type 2 DIAbetes
Condition: Diabetes
Intervention: Drug: 2 different procedures of administration of insulin
25 Unknown  Clinical Assessment of a Closed-loop Insulin Delivery System
Condition: Type 1 Diabetes Mellitus
Intervention: Device: The Imperial College Closed-Loop Insulin Delivery System
26 Recruiting Early Intermittent Intensive Insulin Therapy as an Effective Treatment of Type 2 Diabetes (RESET-IT Main Trial)
Condition: Type 2 Diabetes
Interventions: Drug: Metformin alone;   Drug: Metformin + Intermittent Insulin Therapy
27 Unknown  Best Timing of Insulin Bolus Before Meals of Different Contents
Condition: Type 1 Diabetes Mellitus
Intervention: Drug: insulin
28 Unknown  Study of Combination Therapy of Gliclazide MR and Basal Insulin Versus Insulin Monotherapy to Treat Type 2 Diabetes
Condition: Type 2 Diabetes
Interventions: Drug: Gliclazide MR and Insulin Glargine Injection;   Drug: Biosynthetic Human Insulin Injection
29 Recruiting PK/PD STUDY OF U-500 REGULAR INSULIN
Conditions: Type 2 Diabetes;   Insulin Resistance;   High Insulin Requirements
Intervention: Drug: U-500 insulin
30 Recruiting Insulin Degludec and Symptomatic Nocturnal Hypoglycaemia
Conditions: Type 1 Diabetes Mellitus;   Nocturnal Hypoglycemia;   Recurrent Severe Hypoglycaemia
Interventions: Drug: Insulin aspart/glargine;   Drug: Insulin aspart/degludec
31 Recruiting Study of Nasal Insulin to Fight Forgetfulness - Short-Acting Insulin Aspart
Conditions: Alzheimer's Disease;   Mild Cognitive Impairment
Interventions: Drug: Insulin aspart;   Drug: Placebo
32 Recruiting A Phase III Study of Insulin Aspart Injection to Evaluate the Efficacy and Safety
Condition: Diabetes
Interventions: Biological: insulin Aspart injection;   Biological: insulin Aspart injection (NovoRapid)
33 Recruiting Safety and Efficacy of Albiglutide + Insulin Glargine Versus Insulin Lispro + Insulin Glargine Subjects With Type 2 Diabetes Mellitus
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Albiglutide;   Drug: Insulin Glargine and Insulin Lispro
34 Recruiting Retinal Adaptation to Intensified Insulin Therapy and Bariatric Surgery in Patients With Diabetes
Conditions: Diabetes Mellitus;   Diabetic Retinopathy
Interventions: Other: Insulin pump;   Other: Multiple daily insulin injections;   Procedure: Bariatric surgery;   Other: Medical therapy for type 2 diabetes
35 Recruiting An Administration Method Study of Human Regular U-500 Insulin (LY041001) in Participants With Type 2 Diabetes Mellitus
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Human regular U-500 insulin (CSII);   Drug: Human regular U-500 insulin (MDI)
36 Unknown  Metformin and Sitagliptin Therapy for Adult Patients With Type 2 Diabetes Admitted to the General Medical Unit
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: metformin and sitagliptin;   Drug: insulin glargine and insulin lispro
37 Recruiting Perioperative Insulin, GIK or GLP-1 Treatment in Diabetes Mellitus
Condition: Diabetes Mellitus Type II
Interventions: Drug: Liraglutide;   Drug: Insulin bolus;   Drug: GIK infusion
38 Recruiting Closed-loop Control of Glucose Levels (Artificial Pancreas) for 24 Hours in Adults With Type 2 Diabetes Under Intensive Insulin Therapy
Condition: Type 2 Diabetes
Interventions: Other: 24-hour intervention with multiple daily injections;   Other: 24-hour intervention with closed-loop strategy;   Drug: Insulin;   Device: Insulin pump MiniMed® Paradigm® Veo™;   Device: Continuous Glucose Monitoring System Enlite sensor®
39 Recruiting Intranasal Insulin and Post-stroke Cognition: A Pilot Study
Condition: Stroke
Interventions: Drug: Intranasal Insulin;   Drug: Intranasal saline
40 Recruiting ß-Cell Function and Glycemic Control in Newly Diagnosed Type 2 Diabetic Patients With Moderate Hyperglycemia
Condition: Type 2 Diabetes
Interventions: Drug: Insulin;   Drug: Metformin;   Drug: Sitagliptin

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years